Submissions to the US FDA and DCGI
Aurigene Pharmaceutical Services pharmaceutical microbiology testing department has a BSL-2 compliant lab and a dedicated in-vivo facility for bacterial and fungal infection murine disease models. The team has vast experience in anti-infective drug discovery projects and ran several collaboration projects with innovator pharma companies to discover anti-bacterial and anti-fungal agents. Established in-vitro time-kill kinetics bioequivalence assays for generic products for regulatory submission.
Why Aurigene Pharmaceutical Services for Pharmaceutical Microbiology Testing?
Highly Qualified & Experienced Scientists
Audited by the US FDA with Zero 483 in 2019
BSL-2 Compliant Microbiology Lab
In-vitro pharmaceutical microbiology testing services include:
- Pharmacodynamic studies: Drug-organism interaction
- MIC and MBC: Susceptibility indicators; major parameters used to quantify the activity of an antibacterial agent against the target pathogen
- Time kill kinetics: Information on the time course and rate of antimicrobial activity
- PAE and PA-SME: Information on persistent effects of antibacterial agents
- Resistance development and mutation frequency: Information on the rate of resistance
- Others: Antimicrobial combination/effect of serum proteins on MIC/ biofilm studies
Our dedicated Microbiology labs offer a wide range of infectious models that can be tailored as per customer requirements
Would you like to have a
Virtual Tour of Microbiology Testing Labs! Visit Now
In-vivo Pharmaceutical Microbiology Testing
- Systemic infection models: Acute lethal model to generate POC and determine ED50 - primary screening
- Respiratory tract infection models: Test efficacy of NCEs in highly vascularized tissue like lungs
- Thigh infection models: Test efficacy of NCEs in poorly vascularized tissues like thighs
- Urinary tract infection models: Testability of NCEs to clear UTIs
- Organ burden models: Testability of NCEs to clear the disseminated infection
Aurigene Pharmaceutical Services is
a leading CDMO/CRO
that provides contract research and manufacturing services
Virtual Tour
Contact Us
Other Services
- ADME DMPK Studies
- Animal Facility
- Carrageenan Induced Paw Edema Model
- GLP and non-GLP Toxicology Studies
- In vitro Genotoxicity Testing
- In vivo Micronucleus Assay
- In vivo Pharmacology Studies & Services | In vivo Efficacy
- LPS Induced Paw Edema Model
- Mammalian Cell Micronucleus Test (in vitro Genotox)
- Minimum Inhibitory (MIC) and Minimum Bactericidal Concentration (MBC)
- Murine CT26 colon carcinoma tumor model
- Reverse Passive Cutaneous Arthus Reaction
- Systemic LPS Challenge Induced Cytokine Release Model
- Traditional AMES Assay
x
You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.
If you wish to continue to this external website, click Proceed.